Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth

J Clin Invest. 2021 Jun 15;131(12):e151719. doi: 10.1172/JCI151719.
No abstract available

Publication types

  • Published Erratum